Pharmacotherapy, alternative and adjunctive therapies for eating disorders: findings from a rapid review

Rodan, S.C., Bryant, E., Le, A., Maloney, D., Touyz, S., McGregor, I. S., Maguire, S., National Eating Disorder Research Consortium.

Eating disorders have the highest mortality rates and treatment costs of all mental health conditions. This rapid review summarises the evidence around the use of medications and various alternative therapies in the treatment of eating disorders. The review highlights a lack of effective interventions for the treatment of anorexia nervosa with an urgent need to trial new treatments for this condition. Two medications show some efficacy in treating other eating disorders: the antidepressant drug fluoxetine for the treatment of bulimia nervosa, and the stimulant drug lisdexamfetamine for binge eating disorder. There is some positive evidence emerging from novel therapies that involve brain stimulation technologies. Overall, more high-quality research is needed to discover and develop new medications, and other alternative therapies, to better assist patients with eating disorders.

Facebook IconTwitter IconSoundCloud IconLinkedIn Icon
Bookmark
Bookmark
Facebook IconTwitter IconSoundCloud IconLinkedIn Icon

References

  1. Rodan, S.C., Bryant, E., Le, A., Maloney, D., Touyz, S., McGregor, I. S., Maguire, S., & National Eating Disorder Research Consortium. (2023). Pharmacotherapy, alternative and adjunctive therapies for eating disorders: findings from a rapid review. Journal of Eating Disorders, 11(1): 112. doi: 10.1186/s40337-023-00833-9.
Want to bookmark this resource?You can bookmark resources and get back to them whenever you need.Start Saving ResourcesStart